BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 11416152)

  • 1. Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo.
    Ezhevsky SA; Ho A; Becker-Hapak M; Davis PK; Dowdy SF
    Mol Cell Biol; 2001 Jul; 21(14):4773-84. PubMed ID: 11416152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb.
    Ezhevsky SA; Nagahara H; Vocero-Akbani AM; Gius DR; Wei MC; Dowdy SF
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10699-704. PubMed ID: 9380698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cdk2-dependent phosphorylation and functional inactivation of the pRB-related p130 protein in pRB(-), p16INK4A(+) tumor cells.
    Cheng L; Rossi F; Fang W; Mori T; Cobrinik D
    J Biol Chem; 2000 Sep; 275(39):30317-25. PubMed ID: 10906146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes.
    Lundberg AS; Weinberg RA
    Mol Cell Biol; 1998 Feb; 18(2):753-61. PubMed ID: 9447971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cyclin E renders cyclin D-CDK4 dispensable for inactivation of the retinoblastoma tumor suppressor protein, activation of E2F, and G1-S phase progression.
    Keenan SM; Lents NH; Baldassare JJ
    J Biol Chem; 2004 Feb; 279(7):5387-96. PubMed ID: 14645251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
    Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
    Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK; Medina D
    Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
    Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J
    Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points.
    Mateyak MK; Obaya AJ; Sedivy JM
    Mol Cell Biol; 1999 Jul; 19(7):4672-83. PubMed ID: 10373516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.
    Kitagawa M; Higashi H; Jung HK; Suzuki-Takahashi I; Ikeda M; Tamai K; Kato J; Segawa K; Yoshida E; Nishimura S; Taya Y
    EMBO J; 1996 Dec; 15(24):7060-9. PubMed ID: 9003781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced expression of p16(INK4a) inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes.
    McConnell BB; Gregory FJ; Stott FJ; Hara E; Peters G
    Mol Cell Biol; 1999 Mar; 19(3):1981-9. PubMed ID: 10022885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanin accumulation accelerates melanocyte senescence by a mechanism involving p16INK4a/CDK4/pRB and E2F1.
    Bandyopadhyay D; Medrano EE
    Ann N Y Acad Sci; 2000 Jun; 908():71-84. PubMed ID: 10911949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
    Morris L; Allen KE; La Thangue NB
    Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
    Kiess M; Gill RM; Hamel PA
    Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts.
    Stein GH; Drullinger LF; Soulard A; Dulić V
    Mol Cell Biol; 1999 Mar; 19(3):2109-17. PubMed ID: 10022898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
    Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL
    Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway.
    Santoni-Rugiu E; Falck J; Mailand N; Bartek J; Lukas J
    Mol Cell Biol; 2000 May; 20(10):3497-509. PubMed ID: 10779339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. v-Jun overrides the mitogen dependence of S-phase entry by deregulating retinoblastoma protein phosphorylation and E2F-pocket protein interactions as a consequence of enhanced cyclin E-cdk2 catalytic activity.
    Clark W; Black EJ; MacLaren A; Kruse U; LaThangue N; Vogt PK; Gillespie DA
    Mol Cell Biol; 2000 Apr; 20(7):2529-42. PubMed ID: 10713176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
    Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
    Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest.
    Mann DJ; Jones NC
    Curr Biol; 1996 Apr; 6(4):474-83. PubMed ID: 8723352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.